SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending after its Q4 earnings report, which largely surpassed estimates, yet the stock saw a significant decline. Community discussion is polarized, with bulls viewing the dip as an oversold opportunity, highlighting strong subscriber growth and accelerating ad revenue. Conversely, bears are focused on cautious forward guidance, increased content spending, and the pause in share buybacks tied to a potential major acquisition, fueling concerns about near-term shareholder value.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending due to surging natural gas futures prices, driven by forecasts of an extensive arctic cold snap and polar vortex across the US. This weather-driven demand is igniting a significant short squeeze, with the community actively discussing potential further upside and extreme volatility for leveraged natural gas products.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is driving significant conversation due to recent analyst upgrades and reports of a substantial U.S. SHIELD defense contract, further highlighting its strategic importance in domestic chip manufacturing. The community is actively discussing expectations for an upcoming earnings report, with sentiment boosted by reports of Intel's 2026 server CPU capacity being largely sold out amidst growing AI demand.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a powerful rally to record highs, driven by heightened geopolitical tensions, particularly concerns surrounding President Trump's tariff threats against European allies over Greenland. The community is actively discussing gold's role as a vital safe-haven, with many viewing it as a critical hedge against market instability and potential dollar weakness in a "risk-off" environment. This reflects a broad shift towards tangible assets amidst global uncertainty.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is experiencing extreme volatility and highly polarized community sentiment, with many labeling it a 'rug pull' or 'pump and dump' after sharp price movements. Despite these strong warnings, a segment of the community remains aggressively bullish, anticipating massive gains and a significant event by early February. The ongoing debate also highlights widespread confusion and questions regarding legitimate buying avenues and potential fake tokens.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is experiencing extreme volatility and a significant decline, as natural gas prices surge on forecasts predicting colder U.S. weather and heightened heating demand, triggering a notable short squeeze. The community is actively discussing KOLD's dramatic daily drops and the rapid ascent of its inverse, highlighting the "widowmaker" nature of natural gas markets as traders navigate this weather-driven rally.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a notable price pullback, sparking intense debate among the community, with some advocating to "buy the dip" given historically oversold technical indicators and anticipated strong iPhone demand ahead of upcoming earnings. However, others remain cautious, pointing to broader market "risk-off" sentiment fueled by geopolitical tensions and ongoing concerns regarding Apple's long-term growth prospects and AI innovation compared to peers.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently trending due to compelling positive Phase 1 clinical trial data for its eczema drug, soquelitinib, demonstrating significant efficacy even in treatment-resistant patients. This promising data has sparked community discussions about the drug's blockbuster potential and the possibility of future partnerships within the large atopic dermatitis market. However, sentiment is divided as a recently announced public offering raises concerns about potential dilution, weighing on the stock's performance despite the favorable clinical results.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending due to reports of Zydus Lifesciences considering a significant equity stake or acquisition, following a critical patent extension for its key products until 2041. The community is actively discussing a potential bidding war, believing the company's strong revenue trajectory and extended intellectual property runway make it considerably undervalued. Many see the patent extension as a "game changer," significantly enhancing the company's long-term appeal to major pharmaceutical players.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is generating significant buzz amidst intensified geopolitical focus on Greenland's critical mineral reserves, fueled by Donald Trump's renewed emphasis on national security and Western supply chain independence. The community is actively anticipating a crucial business update call this Thursday, expecting positive announcements regarding project advancements and partnerships. This heightened attention positions CRML as a pivotal player in securing vital rare earth materials and reducing reliance on foreign supply.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zenas BioPharma (NASDAQ:ZBIO) Stock Price Down 7.1% - Time to Sell?

Zenas BioPharma (NASDAQ:ZBIO) Stock Price Down 7.1% - Time to Sell...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas...

Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up After Insider Buying Activity

Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity...

Leon Moulder Jr Acquires 20,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock

Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. bought 20,000 shares of the stock in a transaction that occurred on Friday, January 9th. The stock was acquired at an...

Insider Buying: Zenas BioPharma (NASDAQ:ZBIO) CEO Acquires 30,000 Shares of Stock

Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. bought 30,000 shares of Zenas BioPharma stock in a transaction dated Thursday, January 8th. The shares were acquired at an...

Zenas BioPharma (NASDAQ:ZBIO) CEO Buys $819,000.00 in Stock

Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. bought 50,000 shares of the firm's stock in a transaction on Wednesday, January 7th. The stock was acquired at an average...

ZBIO Tanks Despite Positive Data From Rare Autoimmune Diseases Study

Zenas BioPharma tanks nearly 52% despite positive INDIGO study data where obexelimab cut IgG4-RD flare risk by 56% and met all key endpoints.

Zenas BioPharma (NASDAQ:ZBIO) Trading Down 15.5% Following Analyst Downgrade

Zenas BioPharma (NASDAQ:ZBIO) Trading Down 15.5% on Analyst Downgrade...

Why Zenas BioPharma's Selloff Was Structurally Inevitable

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Zenas Biopharma Inc.

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.00	--	--	N/A
Q3 '25	-$1.04	-$1.22	-17.57%	MISSED
Q2 '25	-$1.04	-$1.25	-20.42%	MISSED
Q1 '25	-$1.13	-$0.80	29.43%	BEAT
Q4 '24	-$1.00	--	--	N/A

ZBIO
Zenas Biopharma Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ZBIO News

ZBIOZenas Biopharma Inc.